Anti-cleaved N-terminal GSDMD 抗体 [EPR20829-408]
Anti-cleaved N-terminal GSDMD antibody [EPR20829-408]
- RabMAb
- Recombinant
- 20ul selling size
- 了解详情
5
(4 Reviews)
|
(240 Publications)
Anti-cleaved N-terminal GSDMD antibody [EPR20829-408] (ab215203) is a rabbit monoclonal antibody detecting cleaved N-terminal GSDMD in Western Blot. Suitable for Human.
- Biophysical QC for unrivalled batch-batch consistency
- Over 110 publications
查看别名
DFNA5L, GSDMDC1, FKSG10, GSDMD, Gasdermin-D, Gasdermin domain-containing protein 1
- WB
Unknown
Western blot - Anti-cleaved N-terminal GSDMD antibody [EPR20829-408] (AB215203)
The lysate was kindly provided by our collaborator Dr Feng Shao's lab, NIBS.
The molecular weight observed is consistent with literature (PMID : 26375003).
Blocking/Dilution buffer : 5% NFDM/TBST.
The N-term cleaved Gasdermin-D needs inflammatory caspases in response to canonical and non-canonical inflammasome activators (PubMed : 31548300, PubMed : 27418190, PubMed : 26375259). If need to detect cleavage of GSDMD, please ensure that the samples are treated with inflammation before testing.
All lanes:
Western blot - Anti-cleaved N-terminal GSDMD antibody [EPR20829-408] (ab215203) at 1/1000 dilution
Lane 1:
Untreated THP-1 (human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
THP-1 treated with 500 ng/ml EprI for 2h, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 53 kDa
Observed band size: 31 kDa
false
Exposure time: 3min
- WB
Unknown
Western blot - Anti-cleaved N-terminal GSDMD antibody [EPR20829-408] (AB215203)
The lysate was kindly provided by our collaborator Dr Feng Shao's lab, NIBS.
The molecular weight observed is consistent with literature (PMID : 26375003).
Blocking/Dilution buffer : 5% NFDM/TBST.
The N-term cleaved Gasdermin-D needs inflammatory caspases in response to canonical and non-canonical inflammasome activators (PubMed : 31548300, PubMed : 27418190, PubMed : 26375259). If need to detect cleavage of GSDMD, please ensure that the samples are treated with inflammation before testing.
All lanes:
Western blot - Anti-cleaved N-terminal GSDMD antibody [EPR20829-408] (ab215203) at 1/1000 dilution
All lanes:
Salmonella Infected (MOI:100) A431 (human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 53 kDa
Observed band size: 31 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-cleaved N-terminal GSDMD antibody [EPR20829-408] (AB215203)
ab215203 mainly recognizes N-terminal GSDMD and ab219800 mainly recognizes full length GSDMD.
Exposure time : Lanes 1-4 : 100 seconds, Lanes 5-6 : 40 seconds.
Lanes 1 - 4:
Western blot - Anti-cleaved N-terminal GSDMD antibody [EPR20829-408] (ab215203) at 1/1000 dilution
Lanes 5 - 6:
Western blot - Anti-GSDMD antibody [EPR20859] (<a href='/products/primary-antibodies/gsdmd-antibody-epr20859-ab219800'>ab219800</a>) at 1/1000 dilution
Lanes 1, 3 and 5:
Untreated THP-1 (human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lanes 2, 4 and 6:
THP-1 (human epidermoid carcinoma cell line) treated with 50ng/ml TPA for 24 hours, then treated with 5ng/ml LPS for 3 hours and add 1μg/ml BFA for another 3 h whole cell lysate at 20 µg
Secondary
Lanes 1, 2, 5 and 6:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Lanes 3 - 4:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/5000 dilution
Observed band size: 31 kDa
false
不同偶联物与剂型 (1)
-
Anti-cleaved N-terminal GSDMD antibody [EPR20829-408] - BSA and Azide free
反应性数据
产品详情
Product Specifications
Anti-cleaved N-terminal GSDMD antibody [EPR20829-408] (ab215203) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in WB in human samples.
Anti-cleaved N-terminal GSDMD antibody [EPR20829-408] (ab215203) specifically detects cleaved N-terminal GSDMD (UniProt ID: P57764; Molecular weight: 53kDa) and is sold in 100 µL and 1 mL selling sizes.
Quality and Validation
Abcam's high quality manufacturing and validation processes ensure Anti-cleaved N-terminal GSDMD antibody [EPR20829-408] (ab215203) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Anti-cleaved N-terminal GSDMD antibody [EPR20829-408] (ab215203) has been cited over 114 times in peer reviewed journals and is trusted by the scientific community.
Related Products
Conjugation-ready, carrier free format available for antibody clone EPR20829-408 - ab255983.
Target Information
Cleaved N-terminal GSDMD (Gasdermin D) is an important protein fragment involved in the execution of pyroptosis, an inflammatory form of cell death. The N-terminal fragment, generated by cleavage, creates pores in the cell membrane, leading to cell death and the release of inflammatory cytokines. Abnormal regulation of cleaved N-terminal GSDMD is associated with various diseases, including inflammatory disorders like rheumatoid arthritis and neurodegenerative diseases such as Alzheimer's disease, contributing to sustained inflammation and tissue damage.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The N-terminal fragment of cleaved GSDMD executes an important role in pyroptosis a type of programmed cell death. This fragment forms pores in the cell membrane allowing the release of pro-inflammatory cytokines. GSDMD does not act alone; it functions as part of a larger molecular complex often interacting with caspases like Caspase-1 and inflammatory molecules which enhance its role in immune responses. The formation of membrane pores by cleaved gasdermin D signifies its fundamental job in enabling cellular defense mechanisms against infections.
Pathways
Cleaved N-terminal GSDMD participates in both pyroptosis and canonical inflammasome pathways. In the inflammasome pathway inflammasomes activate caspases that subsequently cleave GSDMD therefore linking it to a broad inflammatory response. This pathway involves proteins such as Caspase-1 and interleukin-1? which synergize with GSDMD to drive cytokine release. In addition GSDMD cleavage acts downstream of these interactions directly implementing pyroptotic cell death thereby contributing to the body’s innate immune defense.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|zh
靶点信息
文献 (240)
Recent publications for all applications. Explore the full list and refine your search
Cancer biology & therapy 26:2558402 PubMed40947978
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of inflammation research 18:11095-11108 PubMed40831518
2025
Applications
Unspecified application
Species
Unspecified reactive species
Research (Washington, D.C.) 8:0823 PubMed40822127
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular life sciences : CMLS 82:305 PubMed40779242
2025
Applications
Unspecified application
Species
Unspecified reactive species
European journal of medical research 30:715 PubMed40770673
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 135: PubMed40759573
2025
Applications
Unspecified application
Species
Unspecified reactive species
Acta biochimica et biophysica Sinica : PubMed40734554
2025
Applications
Unspecified application
Species
Unspecified reactive species
Mediators of inflammation 2025:3585885 PubMed40726812
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of nanomedicine 20:9111-9134 PubMed40692537
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:21294 PubMed40595708
2025
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com